SPECIFIC BIOLOGICS Trademark

Trademark Overview

On Friday, September 9, 2022, a trademark application was filed for SPECIFIC BIOLOGICS with the United States Patent and Trademark Office. The USPTO has given the SPECIFIC BIOLOGICS trademark a serial number of 97585091. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, September 12, 2024. This trademark is owned by Specific Biologics Inc.. The SPECIFIC BIOLOGICS trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical treatment of genetic diseases and disorders, cystic fibrosis and cancer
specific biologics

General Information

Serial Number97585091
Word MarkSPECIFIC BIOLOGICS
Filing DateFriday, September 9, 2022
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, September 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 15, 2024

Trademark Statements

Goods and ServicesMedical treatment of genetic diseases and disorders, cystic fibrosis and cancer
NOT AVAILABLE"BIOLOGICS"

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 26, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSpecific Biologics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressToronto, Ontario M5G0B
CA

Trademark Events

Event DateEvent Description
Tuesday, September 13, 2022NEW APPLICATION ENTERED
Monday, September 26, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 23, 2023ASSIGNED TO EXAMINER
Wednesday, June 28, 2023NON-FINAL ACTION WRITTEN
Wednesday, June 28, 2023NON-FINAL ACTION E-MAILED
Wednesday, June 28, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 22, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, September 22, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, December 4, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 4, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 5, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 4, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 4, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 4, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 11, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 25, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 4, 2024NON-FINAL ACTION WRITTEN
Monday, March 4, 2024NON-FINAL ACTION E-MAILED
Monday, March 4, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED

Related Keywords

biologics specific cystic fibrosis cancer disorders diseases treatment genetic medical